Eradication of HCV by IFN is thought to reduce HCC occurrence by improving hepatic inflammation, regression of hepatic fibrosis, and the antitumor effects of IFN including tumoricidal, antiproliferative, or immunomodulatory effects31–33. This evidence concerns the gene IFNA1 and hepatocellular carcinoma.